Cadila Healthcare informs about press release

12 Nov 2021 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated November 12, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Eluxadoline Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×